A prospective, multicenter, National Cancer Institute Early Detection Research Network study of [-2]proPSA: improving prostate cancer detection and correlating with cancer aggressiveness

The free prostate-specific antigen (PSA) isoform, [-2]proPSA, has been shown to be associated with prostate cancer. The study objective was to characterize the clinical utility of serum [-2]proPSA for prostate cancer detection and assess its association with aggressive disease. From among 669 subjec...

Celý popis

Podrobná bibliografie

Vydáno v:	Cancer epidemiology, biomarkers & prevention Ročník 19; číslo 5; s. 1193
Hlavní autoři:	Sokoll, Lori J, Sanda, Martin G, Feng, Ziding, Kagan, Jacob, Mizrahi, Isaac A, Broyles, Dennis L, Partin, Alan W, Srivastava, Sudhir, Thompson, Ian M, Wei, John T, Zhang, Zhen, Chan, Daniel W
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States 01.05.2010
Témata:	Adult Aged Aged, 80 and over Humans Male Middle Aged National Cancer Institute (U.S.) Neoplasm Staging Prospective Studies Prostate-Specific Antigen - blood Prostatic Neoplasms - blood Prostatic Neoplasms - diagnosis ROC Curve United States United States
ISSN:	1538-7755
On-line přístup:	Zjistit podrobnosti o přístupu
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!